Evaluation of feasibilty, safety and pleiotropic effects of dapagliflozin -Multicenter trial
Phase of Trial: Phase IV
Latest Information Update: 14 Jan 2019
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors InterSciences
- 10 Jan 2019 Status changed from active, no longer recruiting to completed.
- 13 Jul 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 04 May 2017 Planned initiation date changed from 1 Feb 2017 to 1 May 2017.